Jilin Aodong Pharmaceutical Group Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 3.23% vs -35.42% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 39.46% vs 224.11% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "513.90",
          "val2": "497.80",
          "chgp": "3.23%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-19.40",
          "val2": "16.40",
          "chgp": "-218.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "16.20",
          "val2": "18.10",
          "chgp": "-10.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "185.70",
          "val2": "385.00",
          "chgp": "-51.77%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "976.80",
          "val2": "700.40",
          "chgp": "39.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-37.70%",
          "val2": "-86.50%",
          "chgp": "4.88%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -23.69% vs 20.43% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 5.19% vs -19.81% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,596.50",
          "val2": "3,402.70",
          "chgp": "-23.69%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "99.50",
          "val2": "364.40",
          "chgp": "-72.69%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "94.50",
          "val2": "146.20",
          "chgp": "-35.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-187.00",
          "val2": "-113.70",
          "chgp": "-64.47%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,519.20",
          "val2": "1,444.30",
          "chgp": "5.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-53.50%",
          "val2": "36.70%",
          "chgp": "-9.02%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY

Sep'25

Sep'24

Change(%)

Net Sales

513.90

497.80

3.23%

Operating Profit (PBDIT) excl Other Income

-19.40

16.40

-218.29%

Interest

16.20

18.10

-10.50%

Exceptional Items

185.70

385.00

-51.77%

Consolidate Net Profit

976.80

700.40

39.46%

Operating Profit Margin (Excl OI)

-37.70%

-86.50%

4.88%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Sep 2025 is 3.23% vs -35.42% in Sep 2024

Consolidated Net Profit

YoY Growth in quarter ended Sep 2025 is 39.46% vs 224.11% in Sep 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

2,596.50

3,402.70

-23.69%

Operating Profit (PBDIT) excl Other Income

99.50

364.40

-72.69%

Interest

94.50

146.20

-35.36%

Exceptional Items

-187.00

-113.70

-64.47%

Consolidate Net Profit

1,519.20

1,444.30

5.19%

Operating Profit Margin (Excl OI)

-53.50%

36.70%

-9.02%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is -23.69% vs 20.43% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 5.19% vs -19.81% in Dec 2023

All Annual Results